Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer
Sheng Jin, Wen‐Feng Fang, Xia Liu, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 1101-1110
Open Access | Times Cited: 16

Showing 16 citing articles:

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Kamal Pandey, Hee Jung An, Seung-Ki Kim, et al.
International Journal of Cancer (2018) Vol. 145, Iss. 5, pp. 1179-1188
Open Access | Times Cited: 291
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?
Meng Qiao, Tao Jiang, Xinyu Liu, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 8, pp. 1267-1288
Closed Access | Times Cited: 116
Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions
Ross A. Soo, Sun Min Lim, Nicholas Syn, et al.
Lung Cancer (2017) Vol. 115, pp. 12-20
Closed Access | Times Cited: 155
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
Murad Alahdal, Eyad Elkord
Clinical and Translational Medicine (2023) Vol. 13, Iss. 9
Open Access | Times Cited: 27
Overcoming EGFR-TKI resistance by targeting the tumor microenvironment
Jinsong Zhang, Natalie I. Vokes, Man Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 3, pp. 151-161
Open Access | Times Cited: 4
Immunological effect of tyrosine kinase inhibitors on the tumor immune environment in non‑small cell lung cancer (Review)
Li Jiang, Jiyan Liu
Oncology Letters (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 15
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities
Emily K. Kleczko, Lynn E. Heasley
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Immunotherapy in EGFR mutant non-small cell lung cancer: when, who and how?
Débora S. Bruno, Afshin Dowlati
Translational Lung Cancer Research (2019) Vol. 8, Iss. 5, pp. 710-714
Open Access | Times Cited: 16
A combined preoperative red cell distribution width and carcinoembryonic antigen score contribute to prognosis prediction in stage I lung adenocarcinoma
Hengliang Xu, Guangqiang Zhao, Jixing Lin, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma
Hoi‐Hin Kwok, Jiashuang Yang, David Lam
Cancers (2023) Vol. 15, Iss. 10, pp. 2749-2749
Open Access | Times Cited: 4
Immunological features of EGFR-mutant non-small cell lung cancer and clinical practice: a narrative review
Yi Dong, L Khan, Yi Yao
Journal of the National Cancer Center (2024) Vol. 4, Iss. 4, pp. 289-298
Open Access | Times Cited: 1
Therapeutic Opportunity in Innate Immune Response Induction by Oncogene-Targeted Drugs
Daniel J Sisler, Lynn E. Heasley
Future Medicinal Chemistry (2019) Vol. 11, Iss. 10, pp. 1083-1086
Open Access | Times Cited: 10
The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
Yongdong Feng, Guangkuo Zhu, Song Lang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
Immunological implications of epidermal growth factor receptor signaling in persistent infections
Tanushree Mukherjee, Kithiganahalli Narayanaswamy Balaji
IUBMB Life (2019) Vol. 71, Iss. 11, pp. 1661-1671
Open Access | Times Cited: 1
Possibilities of applying a combination of targeted molecular therapies and immunotherapy in NSCLC patients
Magdalena Wójcik-Superczyńska, Tomasz Jankowski, Paweł Krawczyk
Nowotwory Journal of Oncology (2022) Vol. 72, Iss. 3, pp. 184-189
Open Access
Physicochemical Characterization and Biopharmaceutical Evaluation of ZWF: A Novel Anticancer Drug for the Treatment of Non-small Cell Lung Cancer
Lina Zhao, He Li, Yuan Chen, et al.
AAPS PharmSciTech (2021) Vol. 22, Iss. 6
Closed Access
Page 1

Scroll to top